Last Posted: Apr 03, 2020
- Genetic risk score modifies the effect of APOE on risk and age onset of Alzheimer's disease.
Shi Zhuqing et al. Clinical genetics 2019 95(2) 302-309 - Disclosing genetic risk for Alzheimer's dementia to individuals with mild cognitive impairment.
Christensen Kurt D et al. Alzheimer's & dementia (New York, N. Y.) 2020 6(1) e12002 - Studying the Manifold Structure of Alzheimer's Disease: A Deep Learning Approach Using Convolutional Autoencoders.
Martinez-Murcia Francisco J et al. IEEE journal of biomedical and health informatics 2020 24(1) 17-26 - "Choosing Wisely": Apolipoprotein E Genetic Testing for the Diagnosis of Alzheimer's Disease in Dementia Clinics.
Yang Hyun Ju et al. Journal of Alzheimer's disease : JAD 2020 Mar - A machine learning-based linguistic battery for diagnosing mild cognitive impairment due to Alzheimer's disease.
Orimaye Sylvester Olubolu et al. PloS one 2020 15(3) e0229460 - Another step forward in blood-based diagnostics for Alzheimer’s disease
RJ Bateman et al, Nature Medicine, March 4, 2020 - Sex and APOE ε4 genotype modify the Alzheimer’s disease serum metabolome
M Arnold, Nature Communications, March 2, 2020 - Issues and Questions Surrounding Screening for Cognitive Impairment in Older Patients.
Petersen Ronald C et al. JAMA 2020 Feb (8) 722-724 - [Direct-to-consumer genetic tests in the consulting room].
Gerrits Elianne M et al. Nederlands tijdschrift voor geneeskunde 2019 Nov 163 - Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease.
Ossenkoppele Rik et al. JAMA neurology 2020 Feb
.png)
No hay comentarios:
Publicar un comentario